Gomez-Sanchez C E, Gomez-Sanchez E P, Shackleton C H, Milewich L
Endocrinology. 1982 Feb;110(2):384-9. doi: 10.1210/endo-110-2-384.
The formation of 19-hydroxydeoxycorticosterone (19,21-dihydroxy-4-pregnen-3,20-dione), 19-oxo-deoxycorticosterone (21-hydroxy-4-pregnen-3,19,20-trione), and 19-oic-deoxycorticosterone (19-oic-21-hydroxy-4-pregnen-3,20-dione) from precursor deoxycorticosterone by adrenal glands obtained from intact rats and from rats undergoing adrenal regeneration was demonstrated. These metabolites were isopolar with corresponding authentic steroid standards on thin layer chromatography, gas chromatography, and high pressure liquid chromatography. They were further characterized by either mass spectrometry or gas chromatography-mass spectrometry. Therefore, rat adrenals have the enzymes required to convert deoxycorticosterone to 19-hydroxydeoxycorticosterone, 19-oxo-deoxycorticosterone, and 19-oic-deoxycorticosterone; however, rat adrenals do not convert deoxycorticosterone or any of the oxygenated metabolites to 19-nor-deoxycorticosterone (21-hydroxy-19-nor-4-pregnen-3,20-dione). It is possible, however, that 19-nor-deoxycorticosterone is formed at peripheral sites from the oxygenated deoxycorticosterone precursors.
已证实,从完整大鼠及肾上腺再生大鼠获取的肾上腺,能以前体脱氧皮质酮生成19-羟脱氧皮质酮(19,21-二羟基-4-孕烯-3,20-二酮)、19-氧代脱氧皮质酮(21-羟基-4-孕烯-3,19,20-三酮)及19-羧基脱氧皮质酮(19-羧基-21-羟基-4-孕烯-3,20-二酮)。这些代谢产物在薄层色谱、气相色谱及高压液相色谱上与相应的甾体标准品等极性。它们通过质谱或气相色谱-质谱进一步表征。因此,大鼠肾上腺具备将脱氧皮质酮转化为19-羟脱氧皮质酮、19-氧代脱氧皮质酮及19-羧基脱氧皮质酮所需的酶;然而,大鼠肾上腺不会将脱氧皮质酮或任何氧化代谢产物转化为19-去甲脱氧皮质酮(21-羟基-19-去甲-4-孕烯-3,20-二酮)。不过,19-去甲脱氧皮质酮有可能在外周部位由氧化的脱氧皮质酮前体形成。